A practical reference on IGF-1 marker: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-07-26. Anything still debated is marked as such rather than presented as settled.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
| Property | Value | Notes |
|---|---|---|
| Primary target | Growth hormone-releasing hormone receptor | Located on anterior pituitary somatotroph cells. |
| Receptor class | G protein-coupled receptor | Activation increases intracellular cyclic AMP. |
| Main downstream hormone | Growth hormone and insulin-like growth factor 1 | Growth hormone release precedes IGF-1 elevation. |
| Primary studied effect | Reduction in visceral adipose tissue | Measured by computed tomography in clinical trials. |
| Approximate half-life | 26–38 minutes after subcutaneous administration | Values vary by assay and study population. |
Binding of tesamorelin to the growth hormone-releasing hormone receptor on anterior pituitary somatotrophs activates a Gs protein pathway, raises cyclic AMP, and triggers release of stored growth hormone into the bloodstream. Because the analogue resists dipeptidyl peptidase-4, its plasma residence time exceeds that of native GHRH, producing a larger and more sustained secretory signal. The released growth hormone then acts on the liver and peripheral tissues to raise insulin-like growth factor 1, which feeds back on the hypothalamus and pituitary. This axis explains both the intended effects on fat distribution and the biological markers used to track them.
Studies of the compound rely on imaging and laboratory endpoints rather than on symptoms alone. Visceral adipose tissue is usually quantified by computed tomography or magnetic resonance imaging at the level of the abdomen, with waist circumference serving as a cheaper but less specific proxy. Blood work tracks insulin-like growth factor 1, fasting glucose, glycated hemoglobin, and lipid fractions. In the pivotal trials the imaging endpoint fell by roughly fifteen to twenty percent over six months, subcutaneous fat changed little, and the visceral fat returned toward baseline after treatment stopped, a pattern that shapes how clinicians discuss durability.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
Questions remain about how much of the observed fat reduction reflects direct GHRH-receptor signaling versus the downstream growth hormone and IGF-1 surge. It is also unclear whether the compound produces meaningful benefit in populations without lipodystrophy, since trials in cognitive impairment did not reach their stated goals. Long-term effects on glucose metabolism and on cardiovascular outcomes are not fully characterized. Published work generally describes effects on surrogate markers rather than on hard clinical endpoints, and independent replication of some findings is limited.
Tesamorelin acts on the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in intracellular cyclic AMP, which in turn opens ion channels and raises calcium concentrations, leading to release of stored growth hormone into the bloodstream. Because the peptide works through the same receptor as the body's own GHRH, the resulting secretion follows a pulsatile pattern rather than a continuous elevation. The N-terminal modification slows enzymatic breakdown, so the signal persists longer than it would with the unmodified hormone.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
==== Philanthropy ==== As chairman emeritus of Ferring, Paulsen is a founding sponsor of The Peptide Therapeutics Foundation. He has contributed to the opening of several fertility clinics throughout Russia to help solve its demographics problem. He has donated approximately $40 million to the Museum Kunst der Westküste (Museum of West Coast Art). He has also substantially contributed to the Salk Institute in San Diego, California, Bhutan's Royal Textile Academy and the South Georgia Heritage Trust in Scotland.
homeodomain A nucleic acid-binding domain, typically 60 amino acids in length, found near the C-terminus of certain eukaryotic proteins, characterized by a highly conserved helix-turn-helix motif that binds with strong affinity to the backbone of specific recognition sequences in DNA or RNA molecules. A protein may have one or more homeodomains, each of which is specific to a different recognition sequence. Many homeodomain-containing proteins function as transcription factors by binding to sequences within promoters and blocking or recruiting other proteins, such as RNA polymerase or cofactors of the transcription initiation complex. Homeodomains are the translated versions of homeoboxes, though the terms are often used interchangeably.
Frederick Sanger (; 13 August 1918 – 19 November 2013) was a British biochemist who received the Nobel Prize in Chemistry twice. He won the 1958 Chemistry Prize for determining the amino acid sequence of insulin and numerous other proteins, demonstrating in the process that each had a unique, definite structure; this was a foundational discovery for the central dogma of molecular biology. At the newly constructed Laboratory of Molecular Biology in Cambridge, he developed and subsequently refined the first-ever DNA sequencing technique, which vastly expanded the number of feasible experiments in molecular biology and remains in widespread use today. The breakthrough earned him the 1980 Nobel Prize in Chemistry, which he shared with Walter Gilbert and Paul Berg. He is one of only three people to have won multiple Nobel Prizes in the same category (the others being John Bardeen in physics and Karl Barry Sharpless in chemistry), and one of five persons with two Nobel Prizes.
=== Export markets === The front-wheel-drive 323 was introduced in Europe in September 1980, nearly simultaneously to its cousin and competitor the Ford Escort. The four-door saloon version followed in January 1981, and one month later automatic-equipped models became available to European buyers.
Sources: en.wikipedia.org
=== Endogenous production and effects === In the 1950s, the endogenous production of psychoactive agents was considered to be a potential explanation for the hallucinatory symptoms of some psychiatric diseases; this is known as the transmethylation hypothesis. Several speculative and yet untested hypotheses suggest that endogenous DMT is produced in the human brain and is involved in certain psychological and neurological states. DMT is naturally occurring in small amounts in rat brains, human cerebrospinal fluid, and other tissues of humans and other mammals. Further, mRNA for the enzyme necessary for the production of DMT, INMT, are expressed in the human cerebral cortex, choroid plexus, and pineal gland, suggesting an endogenous role in the human brain. In 2011, Nicholas Cozzi of the University of Wisconsin School of Medicine and Public Health, and three other researchers, concluded that INMT, an enzyme that is associated with the biosynthesis of DMT and endogenous hallucinogens is present in the non-human primate (rhesus macaque) pineal gland, retinal ganglion neurons, and spinal cord. Neurobiologist Andrew Gallimore suggested in 2013 that while DMT might not have a modern neural function, it may have been an ancestral neuromodulator once secreted in psychedelic concentrations during REM sleep, a function now lost.
Narrated by Jonathan Cullen, produced by Andy Paterson, directed by Patrick Forbes 22 September Fighting the G-Force, it looked at the Brooks Air Force Base in Texas; F-16 aircraft of the United States Air Force Thunderbirds; a G-force simulator on 30 May 1997, where a pilot experiences G-LOC; Major Mark Arlinghaus of the Thunderbirds; Captain Rick Forster, an F-16 instructor; Luke Air Force Base in Arizona, where F-16 pilots were trained; Major Rob Kesterson, an instructor with the 62nd Fighter Squadron; Lt Toby Brallier of the 62nd Fighter Squadron, who blacked out, but he was in a two-seat F-16 trainer; Holloman Air Force Base in New Mexico, where all USAF pilots learn about G-LOC, and are medically tested; Captain John Condojani and G-suits; a G-force centrifuge, rotating once every two seconds; pilots referred to G-LOC as 'doing the funky chicken'; to fly in an A-10, a pilot had to cope with 7.5G, and there were no exceptions; F-16 pilots had to cope with 9G; Captain Rick Fofi, a physical training officer with the USAF; women had been allowed to fly USAF fighter aircraft since 1993; Dr William Albery, chief of USAF aerospace medical research; Colonel James Dooley of flight motion effects at Brooks AFB in Texas, in the Armstrong Laboratory, named after Harry George Armstrong, known for the Armstrong limit; taller pilots were more susceptible to G-LOC; when the German Air Force inherited East German pilots, it discovered that the East German air force believed that G-LOC could be prevented by ruthless selection of pilots and better fitness preparation; Wing Commander Andreas Valentiner of the Luftwaffe Institute of Aviation Medicine; the German Air Force decided to ruthlessly select pilots by G-LOC in a centrifuge as well, before any training commenced - it was the only NATO air force to do this; Dr Brendan Godfrey, director of the Armstrong Laboratory; Captain Kelly Greene of Wright-Patterson Air Force Base in Ohio; Colonel Ron Hill, head of the Crew Systems Directorate; Finley Barfield, chief engineer of the F-16, and what became the Automatic Ground Collision Avoidance System, to avoid controlled flight into terrain (CFIT); Dr Paul Werchan of Brooks AFB; Dr Gene McCall of the United States Air Force Scientific Advisory Board; the Northrop Grumman RQ-4 Global Hawk, planned to first fly in late 1997. Narrated by Piers Gibbon, produced by Simon Berthon, directed by Mark Rubens, made by 3BM Television with The Learning Channel (TLC) 29 September The Iceberg Cometh, about the dangers of icebergs in the Atlantic Ocean; for every metre above surface, four metres are below; the icebergs are made of snow that fell half a million years ago; Greenland is as large as western Europe; icebergs can travel thirty miles a day; the International Ice Patrol was formed in 1914, and now checks half a million square miles; patrols take place three times a week from March to July in the Atlantic Marine Ecozone; glaciologist Peter Wadhams of the University of Cambridge; the North Greenland Ice Core Project (NGRIP) began in 1995. Produced by David Frank, directed by Cathy Rogers, made by RDF Television with the Discovery Channel 13 October Coma, on 4 June 1996 a 32-year-old woman was beaten unconscious in New York Central Park; she was one of four women beaten by 22-year-old John Royster, with the last, 62-year-old Evelyn Alvarez on Park Avenue, not surviving, and Royster was caught from a fingerprint, and was sentenced to life without parole in 1998; neurosurgeon Jamshid Ghajar; the Jamaica Hospital Medical Center, where a nine year old boy, Alex, had been hit by a car, and had severe head trauma, and had a head CT scan; the 'second accident' in the first week in hospital, where the brain swelled, and blocked the flow of blood; a tube was inserted into the brain, to release fluid from swelling, known as a ventriculostomy; the New York Hospital Pediatric ICU, now the Weill Cornell Medical Center; on day two, the eye pupils began to dilate, which can indicate brain swelling, and the intracranial pressure increased, until day three: by day twenty, Alex began to show greater responses, and by day 39, he was walking, and will make a good recovery; neurosurgeon Randall Chesnut, of Oregon, now at the University of Washington School of Medicine; Nicole Ward had a car accident, with a brain injury, but makes a good recovery, thanks to the ventriculostomy procedure; the International Conference on Recent Advances in Neurotraumatology (ICRAN) in early September 1996 at the University of Bologna in Rimini in north-east Italy, where new guidelines of the American Academy of Neurology would be disseminated, from work by the Colorado Medical Society in 1991. A US production, narrated by Piers Gibbon, produced by Paula Apsell, directed by Linda Garmon, made by Nova and WGBH. Shown on Nova on 7 October 1997 20 October Superhighway Robbery, an updated repeat 27 October Sun Storm, about geomagnetic storms, with Nicola Fox of the Heliophysics Science Division; Mike Lockwood (physicist); the March 1989 geomagnetic storm and Hydro-Québec's electricity transmission system; Telesat of Ottawa, and the High Altitude Observatory; a warning system for geomagnetic storms, the Cluster satellite network, was to be launched on 4 June 1996 on board Ariane flight V88, but the launch was a disaster; historical solar records at the Armagh Observatory showed how weather fluctuated with solar activity over the years, John Butler found a connection with Earth temperature; Brian Tinsley looked at electrical charge in clouds causing rain, found by aircraft of the National Center for Atmospheric Research (NCAR); Ernest Hildner of the Space Weather Prediction Center; North American Aerospace Defense Command (NORAD); Daniel N. Baker of the Laboratory for Atmospheric and Space Physics; the Advanced Composition Explorer, launched in August 1997, would detect the magnetic polarity of any solar winds. Narrated by Robin Ellis, directed by Dan Chambers, produced by Robert Eagle, made by Eagle & Eagle 3 November Natural Born Genius?, about inherited intelligence; the population geneticist Robert Plomin, who came to London in 1994; bioethicist Jonathan Glover; psychologist Camilla Benbow of Iowa State University, and the Study of Mathematically Precocious Youth; statistician Charles Spearman was the first to conduct research into general intelligence in 1904, and found that schoolchildren who were good at one academic subject were also good at other subjects and vice versa, and invented the term g factor (psychometrics), although Francis Galton had briefly looked at the subject; psychologist Ian Deary of the University of Edinburgh, where much research on intelligence has been conducted; Alfred Binet of France invented the intelligence test, so that low-scoring children could be given extra help; cognitive psychologist Michael Howe of the University of Exeter believed that the 11-plus exams in England, for grammar school entrance, could possibly label children; much educational testing took place in the US, as the government believed in it, by the Educational Testing Service (ETS); psychologist Stephen J. Ceci disputed reading cast-iron outcomes of individual intelligence tests, but nonetheless believed that general intelligence could be predicted across a population as a whole; Chris Allander of the Army School of Recruiting; Michael Howe conducted environmental education research of parental support, and if that was as much a factor as genetic or innate ability - environmental educational research largely ignored any genetic component, which Robert Plomin dismissed; psychologist Sandra Scarr had conducted much research on adopted children, which largely and conclusively proved the case for genetically inherited intelligence and abilities - and she believed that you could only teach subjects to children of whom had enough capability; Robert Plomin's wife, psychologist Judith Dunn, and varying intelligence of children within individual families; identical twins raised apart had identical IQ scores; psychologist Thalia C. Eley of the Institute of Psychiatry, Psychology and Neuroscience; from Robert Plomin's exhaustive adoption genetic studies, he finds a genetic link. Narrated by Barbara Flynn, produced by Rosalind Arden, directed by David Cresswell, made by John Gau Productions. John Gau had made Triumph of the Nerds the year before 10 November Losing It, about the persistence of sportspeople in the face of adversity; Steve Backley, javelin thrower gained three world records and was European champion in 1990 at the age of 21, but at the 1991 World Championships in Athletics in Tokyo, he didn't get past the qualifying round, where he had to throw 82m but he could only manage 78m; a fortnight later he threw 91m, gaining the British and Commonwealth records; mental strength is often the difference between success and failure; Doug Sanders, the American golfer, missed a straightforward put at the 1970 British Open; Sally Gunnell at the 1992 Olympics; sports psychologist Dave Collins (a former Royal Marine); footballer Lee Chapman who suffered a loss of confidence in 1982; Sally Gunnell, despite feeling intensely nervous before the final on 19 August of the 1993 World Championships in Athletics in Stuttgart, came first and broke the world record; Scottish golfer Sam Torrance and mental preparation for the zone; cricketer Michael Atherton; tennis player Mark Cox; neuroscientist Susan Greenfield, Baroness Greenfield, and alpha waves or alpha rhythm; banishing negative thoughts; Paul Holmes, sports psychologist of the Great Britain Pistol Squad (run by British Shooting since 2007); total mental absorption, denoted by alpha wave brain activity on an ECG, appeared to strongly help success; psychologist David Milner. Narrated by sports commentator Brian Moore, produced by Geoff Deehan, made by Union Pictures 17 November The Day the Earth Was Hit, the Tunguska event on 30 June 1908; David Morrison (astrophysicist) of NASA Ames; Duncan Steel of The Spaceguard Foundation; physicist Edward Teller; Russian mineralogist Leonid Kulik lead the investigation in 1927; the Tunguska explosion had the strength of a 15 megatonne nuclear explosion; astrophysicist Victor Clube and Bill Napier of Armagh Observatory; scientists from Tomsk State University visit Vanavara (rural locality) in the Siberian summer; the 1945 nuclear explosions had similarities in explosive effect to the Tunguska event; Benny Peiser; the Beta Taurids meteor shower; geochemist Evgeny Kolesnikov of Moscow University; tests at Sandia National Laboratories by Mark Boslough; astronomer Eleanor F. Helin of JPL, who worked on the Near-Earth Asteroid Tracking programme. Narrated by Anthony Hyde, produced by Simon Welfare, directed by Stephen White, made by Granite Productions 24 November When Pigs Ruled the World, about the species that survived the extinction event 250 million years ago, to give rise to mammals; Roger Smith of the South African Museum in the Karroo desert; Scottish paleontologist Mike Benton of the University of Bristol; Peter Ward (paleontologist) of the University of Washington; around 1977 a farmer found a strange footprint, made by a therapsid, the ancestor of mammals, in the Guadalupian part of the middle Permian; biologist Colin Tudge, and how large genetic variety was needed for rapid natural selection to occur, to go from sauropsids to synapsids; animatronics technician Neill Gorton would develop a working moving model; the Moschops plant eater, the more dangerous carnivore Anteosaurus, and the slower Lystrosaurus; paleontologists did not know whether therapsids laid eggs, or have birth to live animals; nasal concha bones; the Permian–Triassic extinction event, 252 million years ago, which scientists did not know the direct cause, and had taken place over 100,000 years; Pangaea was formed 350 million years ago; Tony Hallam of the University of Birmingham, and the events in the Triassic; due the extinction event, Lystrosaurus became much greater in number, as its predators had become extinct; small reptiles evolved into the dinosaurs, and Lystrosaurus evolved into rodents; loss of species was being counted on Madagascar; conservationist Joanna Durbin (now of the Climate, Community & Biodiversity Alliance) and the population of Lemur monkeys on Madagascar; Colin Tudge believed that mass extinctions were integral to evolution; Lystrosaurus lasted for ten million years. Narrated by Roger Allam, produced by Joanne Reay, directed by Howard Reay, made by The Mission, with the Discovery Channel 1 December Mindreaders, about autistic traits; Simon Baron Cohen at Cambridge; Temple Grandin in east Colorado; experimental psychologist Alison Gopnik of the University of California, Berkeley; the Sally–Anne test; Helen Tager-Flusberg, and Williams syndrome; Nancy Etcoff of Harvard Medical School; Phineas Gage; neurologist Robert T. Knight of UC Berkeley; Turner syndrome, where females miss the other X chromosome, and have autistic characteristics; David Skuse of the UCL Great Ormond Street Institute of Child Health found that if this X chromosome originated from the mother, the chances of autistic characteristics were much higher; female brains were typically more attuned to faces than male brains; the book An Anthropologist on Mars. Narrated by British actor Bernard Hill, produced by John Wyver, directed by Jeremy Taylor, made by Illuminations Productions. The female actress was Zoe Margolis, later known for Girl with a One-Track Mind 15 December The Conspiracy of Science, about biotechnology companies in Boston (US); David Kent of Genzyme; the Economic Espionage Act of 1996; the murder of Tsunao Saitoh, and his daughter, in May 1996; Steven Rosenberg of the National Cancer Institute; David Blumenthal of Massachusetts General Hospital; a study by Sandoz (now Novartis) into calcium channel blockers, such as felodipine, by Curt Furberg; full disclosure, or lack of any, of known adverse effects remains a greatly controversial subject. Narrated by Neil Pearson, produced by Geoff Deehan, directed by Tim Shawcross, made by Union Pictures with The Learning Channel (TLC) 22 December Moscow, We Have a Problem, about the Mir EO-23 collision in 1997; Mir had a fire on 24 February 1997; Michael Foale travelled to Mir in May 1997 on Atlantis; the father of Michael Foale was an RAF Meteor pilot; Mir had been in orbit since February 1987, 248 miles above the Earth; the shuttle was docked with Mir for five days; cosmonaut Konstantin Feoktistov, designer of Mir; Mir was only meant to last three years; the oxygen that the cosmonauts breathe originates from the crew's urine; on 24 June 1997, due to saving money on a radar system, a manual docking of the Progress resupply vehicle took place, where the Progress vehicle hit a module, side on; NASA never conducted docking without radar, in such a possibly dangerous way; Vladimir Solovyov (cosmonaut), director of the RKA Mission Control Center; cosmonaut Vasily Tsibliyev accidentally disconnected an important power cable; two more cosmonauts arrived to mend the module on 14 August 1997; the two previous cosmonauts returned to Earth; on 15 September 1997, Mir came close to a NASA satellite; the International Space Station would be launched in June 1998, to cost £20bn; Frank L. Culbertson Jr, director from 1995 of the Shuttle–Mir program; Michael Foale returned to Earth on 27 September 1997 after 142 days, on the Atlantis shuttle; cosmonaut Sergei Krikalev. Narrated by Haydn Gwynne, produced by Julian Ware, directed by Patrick Fleming, made by ITN Factual
This process, referred to as peptide stapling, uses non-natural amino acids to facilitate macrocyclization by ring-closing olefin metathesis. In this case, a stapled BH3 helix was identified which specifically activates the mitochondrial apoptotic pathway by antagonizing the sequestration of BH3-only proteins by anti-apoptotic proteins (e.g. Bcl-2, see also intrinsic and extrinsic inducers of the apoptosis). This molecule suppressed growth of human leukemia in a mouse xenograft model. Also in 2004, Harran and co-workers reported a dimeric small molecule that mimics the proapoptotic protein Smac (see mitochondrial regulation in apoptosis). This molecule mimics the N-terminal linear motif Ala-Val-Pro-Ile. Uniquely, the dimeric structure of this peptidomimetic led to a marked increase in activity over an analogous monomer. This binding cooperativity results from the molecule's ability to also mimic the homodimeric structure of Smac, which is functionally important for reactivating caspases. Smac mimetics of this type can sensitize an array of non-small-cell lung cancer cells to conventional chemotherapeutics (e.g. Gemcitabine, Vinorelbine) both in vitro and in mouse xenograft models. Heterocycles are often used to mimic the amide bond of peptides. Thiazoles, for example, are found in naturally occurring peptides and used by researchers to mimic the amide bond of peptides.
Sources: en.wikipedia.org
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.
It does not act directly on adipose tissue as a primary mechanism. Instead, it increases endogenous growth hormone, which then influences lipolysis and fat distribution. The reduction in visceral fat is an indirect pharmacodynamic effect.
Tesamorelin acts upstream at the pituitary to amplify natural pulsatile growth hormone release. Growth hormone injections provide exogenous hormone and bypass pituitary regulation. The two approaches therefore differ in feedback control and hormonal dynamics.
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.